Alexion recalls some Soliris batches

Share this article:

Pricey rare disease drug Soliris is being recalled. Manufacturer Alexion noted in an 8K that it was recalling less than 1% of its stock after tests showed visible particles in the medication. The company says replacing the drugs will cost between $10 million and $25 million, and that the recall affected only products in the US.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.